(VIANEWS) – Super Micro Computer (SMCI), Globus Medical (GMED), BanColombia S.A. (CIB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Super Micro Computer (SMCI)
119.7% sales growth and 29.92% return on equity
Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Super Micro Computer has a trailing twelve months EPS of $12.75.
PE Ratio
Super Micro Computer has a trailing twelve months price to earnings ratio of 59.14. Meaning, the purchaser of the share is investing $59.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.92%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 103.2%, now sitting on 9.25B for the twelve trailing months.
Yearly Top and Bottom Value
Super Micro Computer’s stock is valued at $754.01 at 10:22 EST, way below its 52-week high of $1,077.87 and way higher than its 52-week low of $85.61.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Super Micro Computer’s EBITDA is 4.82.
Previous days news about Super Micro Computer(SMCI)
- According to FXStreet on Tuesday, 20 February, "That’s because Super Micro Computer had raised its FY2024 revenue guidance range substantially, from $10 billion to $11 billion to a new range of $14.3 billion to $14.7 billion.", "Chasing high flyers can lead to life-changing losses, and while Super Micro Computer may be a promising business, no one can promise that the losses in its stock will ever be recovered."
- Zacks investment ideas feature highlights: Costco, ebay, Tesla, QUALCOMM and super micro computer. According to Zacks on Tuesday, 20 February, "Chicago, IL - February 20, 2024 - Today, Zacks Investment Ideas feature highlights Costco (COST Quick QuoteCOST – Free Report) , Ebay (EBAY Quick QuoteEBAY – Free Report) , Tesla (TSLA Quick QuoteTSLA – Free Report) , Qualcomm (QCOM Quick QuoteQCOM – Free Report) and Super Micro Computer (SMCI Quick QuoteSMCI – Free Report) ."
2. Globus Medical (GMED)
112.9% sales growth and 5.31% return on equity
Compared to estimates, globus medical (gmed) Q4 earnings: A look at key metricsHere is how Globus Medical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.47.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 35.62. Meaning, the purchaser of the share is investing $35.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.31%.
Moving Average
Globus Medical’s value is above its 50-day moving average of $51.86 and under its 200-day moving average of $53.55.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51%, now sitting on 1.23B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Globus Medical’s EBITDA is 73.28.
Previous days news about Globus Medical(GMED)
- Globus medical (gmed) Q4 earnings and revenues beat estimates. According to Zacks on Tuesday, 20 February, "While Globus Medical has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
3. BanColombia S.A. (CIB)
57% sales growth and 16.94% return on equity
Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other. It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; financial support to real estate developers and mortgages for individuals and companies; and financial and operating leasing services. The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products. In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; and online and computer banking services. Further, the company provides investment banking services comprising project and acquisition finance, debt and equity capital markets, principal investments, M&A, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment trust, custody, and corporate trust; and digital banking platform, transportation, securities brokerage, maintenance and remodeling, advertising and marketing, and outsourcing services, as well as credit cards. As of December 31, 2020, it operated 1,057 branches; 18,631 banking correspondents; 535 PAMs; 215 kiosks in El Salvador and 137 in Colombia; and 6,124 automatic teller machines. Bancolombia S.A. was incorporated in 1945 and is headquartered in MedellÃn, Colombia.
Earnings Per Share
As for profitability, BanColombia S.A. has a trailing twelve months EPS of $6.63.
PE Ratio
BanColombia S.A. has a trailing twelve months price to earnings ratio of 4.76. Meaning, the purchaser of the share is investing $4.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.94%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 20.7% and a negative 8.4%, respectively.
Moving Average
BanColombia S.A.’s value is above its 50-day moving average of $30.61 and way above its 200-day moving average of $27.66.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 27, 2023, the estimated forward annual dividend rate is 2.86 and the estimated forward annual dividend yield is 9.07%.
Volume
Today’s last reported volume for BanColombia S.A. is 87472 which is 64.98% below its average volume of 249808.
4. Trip.com (TCOM)
21.1% sales growth and 9.16% return on equity
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Trip.com has a trailing twelve months EPS of $1.33.
PE Ratio
Trip.com has a trailing twelve months price to earnings ratio of 31.47. Meaning, the purchaser of the share is investing $31.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.16%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 200% and 14%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Trip.com’s EBITDA is 4.53.
Yearly Top and Bottom Value
Trip.com’s stock is valued at $41.86 at 10:22 EST, below its 52-week high of $43.59 and way above its 52-week low of $30.70.
Moving Average
Trip.com’s value is way higher than its 50-day moving average of $36.44 and way higher than its 200-day moving average of $35.79.
5. Zynex (ZYXI)
13.2% sales growth and 25.8% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Earnings Per Share
As for profitability, Zynex has a trailing twelve months EPS of $0.43.
PE Ratio
Zynex has a trailing twelve months price to earnings ratio of 28.86. Meaning, the purchaser of the share is investing $28.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Zynex’s EBITDA is 45.79.
Yearly Top and Bottom Value
Zynex’s stock is valued at $12.41 at 10:22 EST, way under its 52-week high of $14.75 and way above its 52-week low of $6.88.
6. Erie Indemnity Company (ERIE)
11% sales growth and 26.99% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $7.74.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 46.49. Meaning, the purchaser of the share is investing $46.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.99%.
Volume
Today’s last reported volume for Erie Indemnity Company is 105817 which is 9.73% below its average volume of 117226.
7. Hyster (HY)
10.9% sales growth and 48.4% return on equity
Hyster-Yale Materials Handling, Inc., through its subsidiaries, designs, engineers, manufactures, sells, and services a line of lift trucks, attachments, and aftermarket parts worldwide. It manufactures components, such as frames, masts, and transmissions; and assembles lift trucks. The company markets its products primarily under the Hyster and Yale brand names to independent Hyster and Yale retail dealerships. It also sells aftermarket parts under the Hyster and Yale, as well as UNISOURCE and PREMIER brands to Hyster and Yale dealers for the service of competitor lift trucks. In addition, the company produces and distributes attachments, forks, and lift tables under the Bolzoni, Auramo, and Meyer brand names; and designs and produces products in the port equipment and rough terrain forklift markets. Further, it designs, manufactures, and sells hydrogen fuel-cell stacks and engines. The company serves light and heavy manufacturers, trucking and automotive companies, rental companies, building materials and paper suppliers, lumber, metal products, warehouses, retailers, food distributors, container handling companies, and U.S. and non-U.S. governmental agencies. Hyster-Yale Materials Handling, Inc. was incorporated in 1991 and is headquartered in Cleveland, Ohio.
Earnings Per Share
As for profitability, Hyster has a trailing twelve months EPS of $6.28.
PE Ratio
Hyster has a trailing twelve months price to earnings ratio of 10.99. Meaning, the purchaser of the share is investing $10.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.4%.
Moving Average
Hyster’s worth is way higher than its 50-day moving average of $61.16 and way higher than its 200-day moving average of $50.71.
8. Kinross Gold (KGC)
5.6% sales growth and 3.93% return on equity
Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. The company operates the Fort Knox mine and the Manh Choh project in Alaska, as well as the Round Mountain and the Bald Mountain mines in Nevada, the United States; the Paracatu mine in Brazil; the La Coipa and the Lobo-Marte project in Chile; the Tasiast mine in Mauritania; and the Great Bear project in Canada. It is also involved in the extraction and processing of gold-containing ores; reclamation of gold mining properties; and production and sale of silver. Kinross Gold Corporation was founded in 1993 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Kinross Gold has a trailing twelve months EPS of $0.34.
PE Ratio
Kinross Gold has a trailing twelve months price to earnings ratio of 14.91. Meaning, the purchaser of the share is investing $14.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.93%.
Sales Growth
Kinross Gold’s sales growth is negative 5.4% for the present quarter and 5.6% for the next.
Moving Average
Kinross Gold’s worth is way below its 50-day moving average of $5.77 and below its 200-day moving average of $5.18.
Yearly Top and Bottom Value
Kinross Gold’s stock is valued at $5.07 at 10:22 EST, way under its 52-week high of $6.34 and way higher than its 52-week low of $3.40.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 28, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 2.18%.
